Twelve-month outcomes of transapical transcatheter aortic valve implantation in patients with severe aortic valve stenosis

Łukasz Wiewiórka; Robert Sobczyński; Jarosław Trębacz; Jerzy Sadowski; Dariusz Dudek; Maciej Stąpór; Janusz Konstanty-Kalandyk; Robert Musiał; Andrzej Gackowski; Krzystof Malinowski; Paweł Kleczyński; Krzysztof Żmudka; Bogusław Kapelak; Jacek Legutko

doi:10.5114/aic.2021.104771

eISSN: 1897-4295
ISSN: 1734-9338

Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2021
vol. 17

Send email

Copy url:

abstract:

Original paper

Twelve-month outcomes of transapical transcatheter aortic valve implantation in patients with severe aortic valve stenosis

Łukasz Wiewiórka

¹

,

Robert Sobczyński

²

,

Jarosław Trębacz

¹

,

Jerzy Sadowski

³

,

Dariusz Dudek

⁴

,

Maciej Stąpór

^{1, 5}

,

Janusz Konstanty-Kalandyk

³

,

Robert Musiał

⁶

,

Andrzej Gackowski

^{5, 7}

,

Krzystof Malinowski

⁸

,

Paweł Kleczyński

⁹

,

Krzysztof Żmudka

⁹

,

Bogusław Kapelak

³

,

Jacek Legutko

⁹

Department of Interventional Cardiology, John Paul II Hospital, Krakow, Poland

Department of Cardiac Surgery and Transplantation, John Paul II Hospital, Krakow, Poland

Jagiellonian University Medical College, Institute of Cardiology, Department of Cardiac Surgery and Transplantation, John Paul II Hospital, Krakow, Poland

Jagiellonian University Medical College, Institute of Cardiology, Krakow, Poland

Nonivasive Cardiovascular Laboratory, John Paul II Hospital, Krakow, Poland

Department of Anaesthesiology and Intensive Therapy, John Paul II Hospital, Krakow, Poland

Jagiellonian University Medical College, Institute of Cardiology, Department of Coronary Artery Disease and Heart Failure, John Paul II Hospital, Krakow, Poland

2nd Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland

Jagiellonian University Medical College, Institute of Cardiology, Department of Interventional Cardiology, John Paul II Hospital, Krakow, Poland

Adv Interv Cardiol 2021; 17, 1 (63): 68–74

DOI: https://doi.org/10.5114/aic.2021.104771

Online publish date: 2021/03/27

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Wiewiórka Ł, Sobczyński R, Trębacz J, et al. Twelve-month outcomes of transapical transcatheter aortic valve implantation in patients with severe aortic valve stenosis. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2021;17(1):68-74. doi:10.5114/aic.2021.104771.

APA

Wiewiórka, Ł., Sobczyński, R., Trębacz, J., Sadowski, J., Dudek, D.,  & Stąpór, M. et al. (2021). Twelve-month outcomes of transapical transcatheter aortic valve implantation in patients with severe aortic valve stenosis. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 17(1), 68-74. https://doi.org/10.5114/aic.2021.104771

Chicago

Wiewiórka, Łukasz, Robert Sobczyński, Jarosław Trębacz, Jerzy Sadowski, Dariusz Dudek, Maciej Stąpór,  and Janusz Konstanty-Kalandyk et al. 2021. "Twelve-month outcomes of transapical transcatheter aortic valve implantation in patients with severe aortic valve stenosis". Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej 17 (1): 68-74. doi:10.5114/aic.2021.104771.

Harvard

Wiewiórka, Ł., Sobczyński, R., Trębacz, J., Sadowski, J., Dudek, D., Stąpór, M., Konstanty-Kalandyk, J., Musiał, R., Gackowski, A., Malinowski, K., Kleczyński, P., Żmudka, K., Kapelak, B.,  and Legutko, J. (2021). Twelve-month outcomes of transapical transcatheter aortic valve implantation in patients with severe aortic valve stenosis. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 17(1), pp.68-74. https://doi.org/10.5114/aic.2021.104771

MLA

Wiewiórka, Łukasz et al. "Twelve-month outcomes of transapical transcatheter aortic valve implantation in patients with severe aortic valve stenosis." Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, vol. 17, no. 1, 2021, pp. 68-74. doi:10.5114/aic.2021.104771.

Vancouver

Wiewiórka Ł, Sobczyński R, Trębacz J, Sadowski J, Dudek D, Stąpór M et al. Twelve-month outcomes of transapical transcatheter aortic valve implantation in patients with severe aortic valve stenosis. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2021;17(1):68-74. doi:10.5114/aic.2021.104771.

Introduction
Transapical access (TA) transcatheter aortic valve implantation (TAVI) (TA-TAVI) represents one of the possible routes in patients with severe aortic stenosis (AS) who are not suitable for transfemoral access. Aim: To assess early- and mid-term clinical outcomes after TA-TAVI.

Material and methods
Patients with severe symptomatic AS undergoing TA-TAVI from November 2008 to December 2019 were enrolled. Clinical and procedural characteristics as well as clinical outcomes including all-cause mortality during 12-month follow-up were assessed.

Results
Sixty-one consecutive patients underwent TA-TAVI for native AS. Patients were elderly with median age of 80.0 (76.0–84.0) years; 55.7% were males. Median baseline EuroSCORE I and STS scores were 18.2% (11.6–27.7) and 4.8% (3.3–8.2), respectively. The procedural success rate was 96.7%. In-hospital, 30-day and 12-month mortality rates were 9.8%; 18.0% and 24.6%, respectively. The main periprocedural and in-hospital complications were bleeding complications (14.8%). The following factors were associated with 12-month mortality: previous cerebrovascular event (CVE), glomerular filtration rate (GFR), aortic valve area (AVA), right ventricular systolic pressure (RVSP) and serum level of N-terminal prohormone of brain natriuretic peptide (NT-proBNP) (RR for CVE 3.17, 95% confidence interval (CI): 1.15–8.76: p = 0.026; RR for AVA per 0.1 cm2 1.28, 95% CI: 1.03–1.55: p = 0.024; RR for GFR per 1 ml/min 0.96: 95% CI: 0.94–0.99: p = 0.007; RR for NT-proBNP per 1000 pg/ml 1.07: 95% CI: 1.01–1.17: p = 0.033; RR for RVSP per 1 mm Hg 1.07: 95% CI 1.02–1.16: p = 0.011).

Conclusions
Transapical TAVI in high-risk patients provides good hemodynamic results with acceptable outcomes.

keywords:

aortic stenosis, high-risk patients, outcomes, transcatheter aortic valve implantation, transapical Summary Transapical transcatheter aortic valve implantation in patients who are not suitable for a transfemoral approach gives a good hemodynamic result with significant clinical improvement History of cerebrovascular event, impaired renal function, aortic valve area, increased NT-proBNP and right ventricular systolic pressure level may be associated with higher mortality at the 12-month follow-up